PI (protease inhibitor) – a type of HIV drug.
HIV protease inhibitors include atazanavir, darunavir, fosamprenavir, indinavir, nelfinavir, lopinavir/r (Kaletra), ritonavir, saquinavir and tipranavir.
Drug targets in the virus life cycle
Different protease inhibitors have been developed to treat hepatitis C.
nanotechnology – science working with tiny particles at the level of manipulating individual molecules. This is an exciting field of medicine. Drugs developed with nanotechnology would need much lower drug doses (hopefully cheaper and having fewer side effects) and would be longer lasting (perhaps being taken every2–4 weeks).
ascites – an abnormal accumulation of fluid in the abdomen, a sign of serious liver damage in people with hepatitis C.
primary mutation – see major mutation.
sanctuary site – see compartment site.